세계의 마이크로니들 시장

Highlights:

The global market for microneedles is expected to grow from $1.0 billion in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.

The global market for solid microneedles is expected to grow from $469.1 million in 2023 to $605.8 million by the end of 2028, at a CAGR of 5.2% from 2023 through 2028.

The global market for dissolving microneedles is expected to grow from $106.1 million in 2023 to $139.5 million by the end of 2028, at a CAGR of 5.6% from 2023 through 2028.

Report Scope:

The current report provides detailed information about the microneedle market. It highlights the current and future market potential for microneedles and provides a detailed analysis of the drivers, restraints, challenges, and opportunities in the market. The report also covers market projections for 2028 and includes the market rankings of key market players. It also covers the competitive environment and regulatory scenario.

The report details the market share of microneedles based on product and application. Based on product, the market is segmented into solid microneedles, hollow microneedles, coated microneedles, dissolving microneedles, and hydrogel microneedles. Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications. Hydrogel and disease diagnosis applications that are covered in the report are not commercially approved and are being used primarily by research organizations.

The market has been divided by geography into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region comprises countries such as the U.S. and Canada; Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; and Asia-Pacific includes China, India, Japan, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as the historical years and for 2022 as the base year, with forecasts for 2028.

Report Includes:

• 30 data tables and 37 additional tables
• An overview of the global market for microneedles
• Analysis of the global market trends, featuring historical revenue data for 2020 to 2022, estimated figures for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028
• Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by type, application and geographical region
• A look at the key market dynamics, the industry structure, regulatory landscape, current outlook and an analysis of the COVID-19 impact on the market for medical devices and microneedles
• Discussion of the properties of the latest generation of smart microneedles, such as skin adhesion, dissolvability, responsiveness and tip-substrate detachability, as well as whether they are bionic, bioderived or biocompatible in nature
• Review of patents on microneedle array technologies by assignee and products in the pipeline
• Coverage of evolving technologies, ESG trends and clinical trials
• Competitive benchmarking of key players, categorized by dermatology and vaccine and drug delivery, and their growth strategies
• Profiles of leading market participants

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in This Report?
• Research Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Highlights of the Market for Microneedles

Chapter 3 Market Overview

• Overview
• History
• Microneedle Materials and Manufacturing
• Microneedle Pipeline
• Regulatory Landscape
• Product Recalls

Chapter 4 Market Dynamics

• Market Drivers
• Potential Applications of Microneedles
• Rising Demand for Dermatology Procedures
• Increasing Number of Infectious Diseases
• Rising Demand for Minimally Invasive Drug Delivery
• Market Restraints
• Risks and Limitations of Using Microneedling Devices
• Stringent Regulatory Scenario
• Market Opportunities
• R&D of Microneedles by Key Players
• Market Challenges
• Complex Manufacturing Process
• Impact of COVID-19 on the Microneedle Market

Chapter 5 Market Breakdown by Type of Microneedle

• Market Overview
• Market Share and Forecast
• Solid Microneedles
• Hollow Microneedles
• Dissolving Microneedles
• Coated Microneedles
• Hydrogel Microneedles

Chapter 6 Market Breakdown by Application

• Market Overview
• Market Share and Forecast
• Dermatology
• Immunobiological Administration
• Disease Treatment
• Disease Diagnosis

Chapter 7 Market Breakdown by Region

• Global Market for Microneedles by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Rest of Asia-Pacific
• Rest of the World

Chapter 8 ESG Development

• Introduction to ESG
• Sustainability in Microneedle Industry: An ESG Perspective
• Key ESG Issues
• Microneedle Industry ESG Performance Analysis
• Consumer Attitudes toward ESG in the Microneedle Market
• Case Study
• Concluding Remarks from BCC

Chapter 9 Emerging Technologies

• Introduction
• 3D-Printing Technology in Microneedles
• Drug Monitoring with Microneedles
• Microneedle for Plant Disease Management
• Smart Microneedles
• Nanotechnology-Integrated Microneedles
• Integration of Microneedles into Wearable Devices

Chapter 10 Clinical Trials and Patent Analysis

• Clinical Trial Analysis
• Clinical Trial Analysis, by Type of Study
• Clinical Trial Analysis, by Status
• Clinical Trial Analysis, by Phase
• Clinical Trial Analysis, by Region
• Patent Analysis
• Patents by Year
• Patents by Top Applicant
• Patents by Top Patent Holder
• Patents by Jurisdiction

Chapter 11 Competitive Intelligence

• Market Share Analysis
• Recent Developments of Key Companies

Chapter 12 Company Profiles

• BECTON, DICKINSON AND CO.
• CANDELA CORP.
• CLEARSIDE BIOMEDICAL
• COSMED PHARMACEUTICAL CO. LTD.
• CUTERA
• CYNOSURE
• DEBIOTECH SA
• LTS LOHMANN THERAPIE-SYSTEME AG
• MERCATOR MEDSYSTEMS INC.
• MI.TO.PHARM GMBH
• MICROPOINT TECHNOLOGIES
• NANOBIOSCIENCES LLC
• NANOPASS
• THERAJECT INC.
• VAXESS TECHNOLOGIES INC.

Chapter 13 Appendix: Acronyms